COGNITIVE DYSFUNCTION
Clinical trials for COGNITIVE DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new COGNITIVE DYSFUNCTION trials appear
Sign up with your email to follow new studies for COGNITIVE DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's drug trial halted: Anti-Tau antibody fails to show promise
Disease control TerminatedThis study tested an experimental drug called JNJ-63733657, designed to target tau protein tangles in the brain, in people with early Alzheimer's disease. The goal was to see if it could slow down memory and thinking decline compared to a placebo. The trial was stopped early (ter…
Matched conditions: COGNITIVE DYSFUNCTION
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Zap and train: new combo therapy targets sluggish thinking in seniors
Symptom relief TerminatedThis study tested whether combining a computer-based brain training program (Speed of Processing training) with a gentle, non-invasive electrical current applied to the scalp (alpha-tACS) could improve how quickly older adults with mild cognitive impairment process visual informa…
Matched conditions: COGNITIVE DYSFUNCTION
Phase: NA • Sponsor: Portucalense University • Aim: Symptom relief
Last updated May 17, 2026 04:13 UTC